New Delhi [India], October 29: BD (Becton, Dickinson and Company) India announced the national launch of Sherlock 3CG+ recently through a 4-city roadshow in Delhi, Mumbai, Chennai and Kolkata. In ...

Earlier this year, NanoVibronix announced the development of ENvue Drive, a robotic system. It designed the platform to ...

Work has been completed on two treatment area improvements, both funded by charity Rosemere Cancer Foundation, which will ...

NanoVibronix, Inc. ("NanoVibronix" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems, today issued a letter to shareholders, highlighting the Company's ...

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

BD India has announced the national launch of the Sherlock 3CG+ system across four major cities: Delhi, Mumbai, Chennai, and Kolkata. This cutting-edge technology is poised to transform the placement ...

Mumbai: BD (Becton, Dickinson and Company) India arm has announced the launch of Sherlock 3CG+, a technology designed to improve accuracy and efficiency in peripherally inserted central catheter (PICC ...

BD (Becton, Dickinson and Company) India announced the national launch of Sherlock 3CG+ recently through a 4-city roadshow in Delhi, Mumbai, Chennai and Kolkata. In current Indian clinical practice, ...

-- Peer-reviewed data published in Neurosurgery show that SOLOPASS (R) 2.0 delivers significantly higher accuracy than free-hand EVD placement. -- SOLOPASS (R) 2.0 achieved consistent accuracy across ...

The practice of routinely maintaining PIVC access has not only benefits but also risks. It’s due for a mindset shift, with ...

All products featured on Self are independently selected by Self editors. However, when you buy something through our retail links, Condé Nast may earn an affiliate commission. Collage: Self; Source ...